ArticlePloS one2014

Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell line.

Steven Bhutra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.